A Study to Evaluate the Relative Bioavailability and Food Effect of a VX-118 Tablet Formulation
Completed · Phase 1
Conditions studied: Cystic Fibrosis
In brief
The purpose of this study is to evaluate the relative bioavailability, effect of food on the pharmacokinetic parameters, and safety and tolerability, of a tablet formulation of VX-118 in healthy participants.
Key facts
- Study ID
- NCT06312787
- Run by
- Vertex Pharmaceuticals Incorporated
- People needed
- 15
- Starts
- 2024-04-02
- Expected to finish
- 2024-05-04
- Last updated by the study team
- 2024-06-03
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Celerion - Lincoln — Lincoln, Nebraska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.